Prognostic impact of lymphatic invasion of colorectal cancer: A single-center analysis of 1,616 patients over 24 years

Anticancer Research

Volumn 33, Issue 7, 2013, Pages 2965-2970

  Akagi, Yoshito ^a   Adachi, Yosuke ^a   Ohchi, Takafumi ^a   Kinugasa, Tetsushi ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Lymphatic invasion; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; AGED; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONFERENCE PAPER; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; TUMOR INVASION; TUMOR LOCALIZATION; TUMOR VOLUME;

COLORECTAL CANCER; LYMPHATIC INVASION; PROGNOSIS;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TIME FACTORS;

EID: 84883287891     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone AM, Pan L, Anderson RN, Fulton JE, Kohler BA, Jemal A, Ward E, Plescia M, Ries LA and Edwards BK: Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 118: 2338-2366, 2012.
2. Coleman MP, Forman D, Byrant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA and the ICBP Module 1 Working Group: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet 377: 127-138, 2011.
3. Kay M: Colorectal carcinoma: Selected issues in pathologic examination and staging and determination of prognostic factors. Arch Pathol Lab Med 132: 1600-1607, 2008.
4. Manilich EA, Kiran RP, Radivoyevitch T, Lavery I, Fazio VW and Remzi FH: A novel data-driven prognostic model for staging of colorectal cancer. J Am Coll Surg 213: 579-588, 2011.
5. Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, Ballario E, Becchi G, Bonilauri S, Carobbi A, Cavaliere P, Garcea D, Giuliani L, Morziani E, Mosca F, Mussa A, Pasqualini M, Poddie D, Tonetti F, Zardo L and Rosso R: Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: Results of a secondary analysis of a large scale adjuvant trial. Ann Surg 235: 458-463, 2002.
6. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10: 65-71, 2003.
7. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J and Virnig BA: Lymph node evaluation in colorectal cancer patients: A population-based study. J Natl Cancer Inst 97: 219-225, 2005.
8. Morris EJ, Maughan NJ, Forman D and Quirke P: Identifying stage III colorectal cancer patients: The influence of the patient, surgeon, and pathologist. J Clin Oncol 25: 2573-2579, 2007.
9. Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, Vieth M, Hoefler G and Langner C: Intramural and extramural vascular invasion in colorectal cancer: Prognostic significance and quality of pathology reporting. Cancer 118: 628-638, 2012.
10. Sejben I, Bori R and Csemi G: Venous invasion demonstrated by orcein staining of colorectal carcinoma specimens is associated with the development of distant metastasis. J Clin Pathol 63: 575-578, 2010.
11. Schoppmann A, Tamandl D, Herberger B, Langle F, Birner P, Geleff S, Grunberger T and Schoppmann SF: Comparison of lymphangiogenesis between primary colorectal cancer and corresponding liver metastases. Anticancer Res 31: 4605-4611, 2011.
12. Shirouzu K, Isomoto H, Morodomi T and Kakegawa T: Carcinomatous lymphatic permeation: Prognostic significance in patients with rectal carcinoma, a long term prospective study. Cancer 75: 4-10, 1995.
13. Japanese Society for Cancer of the Colon and Rectum: General Rules for Clinical and Pathological Studies on Cancers of Colon, Rectum and Anus. Sixth ed. Tokyo: Kanehara & Co., 1998.
14. Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum: Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2010 for the Treatment of Colorectal Cancer. Int J Clin Oncol 17: 1-29, 2012.
15. Sobin LH, Gospodarowicz MK and Wittekond C: TNM Classification of Malignant Tumours. Seventh edition. Wiley- Blackwell, Chichester, 2010.
16. Bilimoria KY, Bentrem DJ, Stewart AK, Talamonti MS, Winchester DP, Russell TR and Ko CY: Lymph node evaluation as a colon cancer quality measure: A National Hospital Report Card. J Natl Cancer Inst 100: 1310-1317, 2008.
17. Gonen M, Schrag D and Weiser MR: Nodal staging score: A tool to assess adequate staging of node-negative colon cancer. J Clin Oncol 27: 6166-6171, 2009.
18. George S, Primrose J, Talbot R, Smith J, Mullee M, Bailey D, du Boulay C, Jordan H; Wessex Colorectal Cancer Audit Working Group. Will Rogers revisited: Prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br J Cancer 95: 841-847, 2006.
19. Namm J, Ng M, Roy-Chowdhury S, Morgan JW, Lum SS and Wong JH: Quantitating the impact of stage migration on staging accuracy in colorectal cancer. J Am Coll Surg 207: 882-887, 2008.
20. Sjo OH, Merok MA, Svindland A and Nesbakken A: Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 55: 307-312, 2012.
21. Chou JF, Row D, Gonen M, Liu YH, Schrag D and Weiser MR: Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer. Cancer 116: 2560-2570, 2010.
22. Wang H, Safar B, Wexner S, Zhao R, Cruz-Correa M and Berho M: Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: Does the same standard apply? Dis Colon Rectum 52: 549-557, 2009.
23. Ha YH, Jeong SY, Lim SB, Choi HS, Hong YS, Chang HJ, Kim DY, Jung KH and Park JG: Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg 252: 336-340, 2010.
24. Marks JH, Valsdottir EB, Rather AA, Nweze IC, Newman DA and Chernick MR: Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer. Dis Colon Rectum 53: 1023-1029, 2010.
25. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ and Haller DG: Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23: 8706-8712, 2005.
26. Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, Grebner A, Ulm K, Hofler H, Nekarda H and Siewert JR: Prognosis of patients with colorectal cancer is associated with lymph node ratio: A single-center analysis of 3026 patients over a 25-year time period. Ann Surg 248: 968-978, 2008.
27. Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, Perez de Arenaza D and Bonadeo FA: Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum 52: 1244-1250, 2009.
28. Moug SJ, Saldanha JD, McGregor JR, Balsitis M and Diament RH: Positive lymph node retrieval ratio optimizes patient staging in colorectal cancer. Br J Cancer 100: 1530-1533, 2009.
29. Yasuda K, Inomata M, Shiromizu A, Shiraishi N, Higashi H and Kitano S: Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection. Dis Colon Rectum 50: 1370-1376, 2007.
30. Wasif N, Faries MB, Saha S, Turner RR, Wiese D, McCarter MD, Shen P, Stojadinovic A and Bilchik AJ: Predictors of occult nodal metastasis in colon cancer: Results from a prospective multicenter trial. Surgery 147: 352-357, 2010.
31. Gertler R, Rosenberg R, Schuster T and Friess H: Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy. Eur J Cancer 45: 2992-2999, 2009.
32. Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD and Weiser MR: Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis Colon Rectum 51: 503-507, 2008.
33. Tominaga K, Nakanishi Y, Nimura S, Yoshimura K, Sakai Y and Shimoda T: Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis Colon Rectum 48: 92-100, 2005.
34. Kajiwara Y, Ueno H, Hashiguchi Y, Mochizuki H and Hase K: Risk factors of nodal involvement in T2 colorectal cancer. Dis Colon Rectum 53: 1393-1399, 2010.